Synairgen plc (SYNAIRGEN) aksje
SYGGF
Forsinket 0 min$0.00010.0000 (0.00%)
Laster graf...
SYNAIRGEN
Market Cap
$110,266
Åpning0.0141
Høy0.0141
Lav0.0141
Volum10k
P/EN/A
Markedsverdi110.27k
52-ukers høy0.0141
52-ukers lav0.0000
Gj.sn. volum20
UtbytteN/A
BetaN/A
EPS-0.0300
Om Synairgen plc (SYNAIRGEN) aksje
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of severe viral lung infections that is in pre- clinical trial; and inhaled interferon beta IFN-ß, a naturally occurring protein, which orchestrates the body's antiviral responses. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.
Selskapsinformasjon
Børs: OTC Markets OTCPK (PNK)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
Mailpoint 810
SO16 6YD Southampton, United Kingdom
SO16 6YD Southampton, United Kingdom
Telefon: + 44 23 8051 2800
Nettside: https://www.synairgen.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål